ASP-9521

Details

Stereochemistry	ACHIRAL
Molecular Formula	C19H26N2O3
Molecular Weight	330.4213
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

COC1=CC2=C(NC(=C2)C(=O)N3CCC(CC(C)(C)O)CC3)C=C1

InChI

InChIKey=OXSCPDKUZWPWFR-UHFFFAOYSA-N

InChI=1S/C19H26N2O3/c1-19(2,23)12-13-6-8-21(9-7-13)18(22)17-11-14-10-15(24-3)4-5-16(14)20-17/h4-5,10-11,13,20,23H,6-9,12H2,1-3H3

HIDE SMILES / InChI

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Aldo-keto reductase family 1 member C3 2 Target ID: P42330\|\|\|Q9UII3 Gene ID: 8644.0 Gene Symbol: AKR1C3 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/24981575	Inhibitor 8504		11.0 nM [IC50]

C_max

Value	Dose	Analyte	Population
913 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24771350/	30 mg single, oral dose: 30 mg route of administration: Oral experiment type: SINGLE co-administered:	ASP-9521 plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: MALE food status: FASTED
3148 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24771350/	100 mg single, oral dose: 100 mg route of administration: Oral experiment type: SINGLE co-administered:	ASP-9521 plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: MALE food status: FASTED
7033 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24771350/	300 mg single, oral dose: 300 mg route of administration: Oral experiment type: SINGLE co-administered:	ASP-9521 plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: MALE food status: FASTED
13651 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24771350/	600 mg single, oral dose: 600 mg route of administration: Oral experiment type: SINGLE co-administered:	ASP-9521 plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: MALE food status: FASTED
6634 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24771350/	100 mg 1 times / day multiple, oral dose: 100 mg route of administration: Oral experiment type: MULTIPLE co-administered:	ASP-9521 plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: MALE food status: FASTED
2277 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24771350/	30 mg 1 times / day multiple, oral dose: 30 mg route of administration: Oral experiment type: MULTIPLE co-administered:	ASP-9521 plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: MALE food status: FASTED

AUC

Value	Dose	Analyte	Population
30745 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24771350/	30 mg single, oral dose: 30 mg route of administration: Oral experiment type: SINGLE co-administered:	ASP-9521 plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: MALE food status: FASTED
98708 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24771350/	100 mg single, oral dose: 100 mg route of administration: Oral experiment type: SINGLE co-administered:	ASP-9521 plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: MALE food status: FASTED
320369 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24771350/	300 mg single, oral dose: 300 mg route of administration: Oral experiment type: SINGLE co-administered:	ASP-9521 plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: MALE food status: FASTED
539312 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24771350/	600 mg single, oral dose: 600 mg route of administration: Oral experiment type: SINGLE co-administered:	ASP-9521 plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: MALE food status: FASTED
108693 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24771350/	100 mg 1 times / day multiple, oral dose: 100 mg route of administration: Oral experiment type: MULTIPLE co-administered:	ASP-9521 plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: MALE food status: FASTED
41251 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24771350/	30 mg 1 times / day multiple, oral dose: 30 mg route of administration: Oral experiment type: MULTIPLE co-administered:	ASP-9521 plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: MALE food status: FASTED

T_1/2

Value	Dose	Analyte	Population
30.4 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24771350/	30 mg single, oral dose: 30 mg route of administration: Oral experiment type: SINGLE co-administered:	ASP-9521 plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: MALE food status: FASTED
23.4 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24771350/	100 mg single, oral dose: 100 mg route of administration: Oral experiment type: SINGLE co-administered:	ASP-9521 plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: MALE food status: FASTED
26.3 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24771350/	300 mg single, oral dose: 300 mg route of administration: Oral experiment type: SINGLE co-administered:	ASP-9521 plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: MALE food status: FASTED
22.2 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24771350/	600 mg single, oral dose: 600 mg route of administration: Oral experiment type: SINGLE co-administered:	ASP-9521 plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: MALE food status: FASTED

Name

Type

Language

ASP-9521

Code

English

ASP 9521

Preferred Name

English

(4-(2-HYDROXY-2-METHYLPROPYL)-1-PIPERIDINYL)(5-METHOXY-1H-INDOL-2-YL)METHANONE

Systematic Name

English

ASP9521

Code

English

METHANONE, (4-(2-HYDROXY-2-METHYLPROPYL)-1-PIPERIDINYL)(5-METHOXY-1H-INDOL-2-YL)-

Systematic Name

English

Code System Code Type Description

SMS_ID

300000042376